Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMRK
2551
CALL
Vivmark Residential
VMRK
$26.1B
| $5.44M | ﹤0.01% |
82,500
+15,500
| +23% | +$969K |
|
|
AFTR
2552
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
| $5.44M | ﹤0.01% |
525,000
-20,000
| -4% | -$206K |
|
2553
MacroGenics
MGNX
$260M
| $5.43M | ﹤0.01% |
1,014,549
-939,801
| -48% | -$5.8M |
|
2554
Floor & Decor
FND
$5.68B
| $5.42M | ﹤0.01% |
52,179
-1,240
| -2% | -$119K |
|
2555
Minerals Technologies
MTX
$2.25B
| $5.42M | ﹤0.01% |
94,024
+43,175
| +85% | +$2.51M |
|
2556
Ardmore Shipping
ASC
$721M
| $5.41M | ﹤0.01% |
438,460
-1,135,582
| -72% | -$15.2M |
|
|
PDS
2557
Precision Drilling
PDS
$1.16B
| $5.41M | ﹤0.01% |
110,934
-169,705
| -60% | -$8.1M |
|
2558
Prestige Consumer Healthcare
PBH
$2.43B
| $5.41M | ﹤0.01% |
91,094
+67,017
| +278% | +$4.01M |
|
2559
Benchmark Electronics
BHE
$2.65B
| $5.41M | ﹤0.01% |
209,441
-342,563
| -62% | -$7.92M |
|
|
ALLK
2560
DELISTED
Allakos
ALLK
| $5.4M | ﹤0.01% |
1,238,703
+343,338
| +38% | +$1.54M |
|
2561
CRA International
CRAI
$1.08B
| $5.39M | ﹤0.01% |
52,890
-28,774
| -35% | -$2.9M |
|
2562
Enterprise Financial Services Corp
EFSC
$2.3B
| $5.38M | ﹤0.01% |
137,715
+121,556
| +752% | +$5.03M |
|
2563
CALL
Welltower
WELL
$173B
| $5.38M | ﹤0.01% |
66,500
+16,100
| +32% | +$1.24M |
|
2564
Vipshop
VIPS
$6.4B
| $5.37M | ﹤0.01% |
325,414
+116,398
| +56% | +$1.82M |
|
2565
Credit Acceptance
CACC
$6.23B
| $5.37M | ﹤0.01% |
10,564
+3,528
| +50% | +$1.65M |
|
2566
Willis Towers Watson
WTW
$31.5B
| $5.36M | ﹤0.01% |
22,761
-310,415
| -93% | -$71.5M |
|
2567
Vera Therapeutics
VERA
$2.49B
| $5.36M | ﹤0.01% |
333,689
-1,553,662
| -82% | -$14M |
|
|
RPC
2568
Ridgepost Capital
RPC
$960M
| $5.35M | ﹤0.01% |
473,603
+155,880
| +49% | +$1.65M |
|
2569
Independent Bank
INDB
$3.9B
| $5.35M | ﹤0.01% |
120,192
-3,835
| -3% | -$199K |
|
2570
iShares Russell 1000 Growth ETF
IWF
$127B
| $5.35M | ﹤0.01% |
77,752
-66,960
| -46% | -$4.26M |
|
2571
Silgan Holdings
SLGN
$4.42B
| $5.34M | ﹤0.01% |
113,923
-351,360
| -76% | -$17.1M |
|
2572
Selective Insurance
SIGI
$5.5B
| $5.34M | ﹤0.01% |
55,615
-134,395
| -71% | -$13.2M |
|
2573
GXO Logistics
GXO
$5.5B
| $5.34M | ﹤0.01% |
84,927
+76,337
| +889% | +$4.28M |
|
2574
PUT
Cintas
CTAS
$81.7B
| $5.32M | ﹤0.01% |
42,800
+36,800
| +613% | +$4.32M |
|
2575
Zentalis Pharmaceuticals
ZNTL
$367M
| $5.31M | ﹤0.01% |
188,320
+158,926
| +541% | +$3.81M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.